Core Points - The document outlines the rules for the Audit Committee of Beijing Innotech Biotechnology Co., Ltd, emphasizing the importance of pre-audit and professional audit to ensure effective supervision of the management by the board of directors [1][2] - The Audit Committee is responsible for reviewing financial information, supervising internal and external audits, and ensuring compliance with relevant laws and regulations [3][4] Group 1: General Provisions - The Audit Committee is established as a specialized committee under the board of directors, responsible for auditing and supervising financial information and internal controls [1][2] - The company does not have a supervisory board; the Audit Committee assumes the powers of a supervisory board as per the Company Law [1] Group 2: Composition of the Committee - The Audit Committee consists of three directors, with a majority being independent directors, and at least one member must be a professional accountant [2] - The chairperson of the Audit Committee is elected from among the independent directors with accounting expertise [2] Group 3: Responsibilities and Authority - The main responsibilities of the Audit Committee include supervising external audits, reviewing financial reports, and ensuring the integrity of internal controls [3][4] - The committee has the authority to propose the hiring or dismissal of external auditors and to review financial reports before submission to the board [4][5] Group 4: Meetings and Procedures - The Audit Committee must meet at least quarterly, and additional meetings can be called as necessary [6][7] - A quorum for meetings requires the presence of at least two-thirds of the committee members, and decisions must be made by a majority vote [7][8] Group 5: Information Disclosure - The company is required to disclose the Audit Committee's annual performance and meeting details alongside its annual report [9][10] - If the board does not adopt the Audit Committee's recommendations, the company must disclose the reasons for this decision [9][10]

Core Points - The article outlines the rules for the Strategic Committee of Beijing Innotech Biotechnology Co., Ltd, aimed at enhancing the company's strategic development and decision-making processes [1][4][9] Group 1: General Provisions - The rules are established to adapt to the strategic development needs of the company, enhance core competitiveness, and improve decision-making quality [1] - The Strategic Committee is a specialized committee under the Board of Directors, responsible for researching and proposing recommendations on the company's long-term development strategy and major investment decisions [1][4] Group 2: Composition of the Committee - The Strategic Committee consists of three directors, including at least one independent director [3] - Members are nominated by the Chairman, a majority of independent directors, or more than one-third of all directors, and elected by the Board [3][4] - The term of the Strategic Committee aligns with that of the Board, and members who cease to be directors automatically lose their committee membership [4] Group 3: Responsibilities and Authority - The main responsibilities include understanding economic trends, evaluating strategic plans, and researching major investment and financing proposals [4] - The committee is tasked with checking the implementation of these matters and must submit proposals to the Board for review [4][5] - If the Board does not fully adopt the committee's recommendations, it must document the committee's opinions and reasons for non-adoption [5] Group 4: Committee Meetings - The Strategic Committee meets as needed, with a minimum of two members able to call for a meeting [5] - Meetings require the presence of at least two-thirds of the members to be valid, and decisions must be approved by a majority [5][6] - The committee can invite company directors and senior management to attend meetings and may request relevant information from the company [6][7] Group 5: Confidentiality and Record Keeping - Members have a confidentiality obligation regarding meeting discussions and must not disclose information without authorization [8] - Meeting records must be kept for at least ten years, and independent directors' opinions should be documented [8][9]

Core Viewpoint - The document outlines the rules and regulations governing the Compensation and Assessment Committee of Beijing Innotech Biotechnology Co., Ltd., focusing on the establishment of a robust assessment and incentive mechanism for directors and senior management, in compliance with relevant laws and regulations [1][2]. Group 1: General Provisions - The purpose of the rules is to enhance the assessment and incentive mechanisms for the company's directors and senior management, improving corporate governance structures [1]. - The Compensation and Assessment Committee is a specialized committee under the board of directors, responsible for formulating assessment standards and compensation policies for directors and senior management [1][2]. Group 2: Composition of the Committee - The committee consists of three directors, with independent directors making up the majority [2]. - The committee members are nominated by the chairman, a majority of independent directors, or more than one-third of all directors, and elected by the board [2]. Group 3: Responsibilities and Authority - The committee is tasked with developing assessment standards, reviewing compensation policies, and making recommendations on various matters, including compensation for directors and senior management [4]. - The board has the authority to reject any compensation plans that may harm shareholder interests [4]. Group 4: Evaluation Procedures - The committee requires the company to provide relevant materials for performance evaluation, including financial indicators and management responsibilities [12]. - The evaluation process involves self-assessment by directors and senior management, followed by performance evaluations conducted by the committee [13]. Group 5: Committee Meetings - The committee meets as needed, with meetings called by the chairman or upon request from committee members [14]. - A quorum for meetings requires the presence of at least two-thirds of the committee members, and decisions are made by a majority vote [15][16]. Group 6: Documentation and Confidentiality - Meeting minutes must be recorded, including the opinions of independent directors, and must be kept for at least ten years [10]. - All committee members are bound by confidentiality regarding the matters discussed in meetings [10].

北京英诺特生物技术股份有限公司 董事会秘书工作细则 （2025年8月修订） 北京英诺特生物技术股份有限公司 董事会秘书工作细则 第一章 总则 第一条 为了促进北京英诺特生物技术股份有限公司（以下简称 "公司"）的规范运作，充分发挥董事会秘书的作用，加强对董事会 秘书工作的管理与监督，根据《中华人民共和国公司法》 （以下简称 "《公司法》"） 、《中华人民共和国证券法》 （以下简称" 《证券法》 《上市公司治理准则》 、《上海证券交易所科创板股票上市规则》、 （以下简称" 《公司章程》" ）等有关规定，制定本工作细则。 第二条 公司设董事会秘书一名，是公司的高级管理人员。公司 董事会秘书是公司与上海证券交易所之间的指定联络人，应当忠实、 勤勉地履行职责，对公司和董事会负责，承担法律、法规及《公司章 程》对公司高级管理人员所要求的义务，享有相应的工作职权，并获 取相应报酬。 第三条 公司应当为董事会秘书履行职责提供便利条件，董事及 其他高级管理人员和公司有关人员应当支持、配合董事会秘书的工作。 第二章 任职资格 第四条 董事会秘书的任职资格： （一）具有良好的职业道德和个人品质； （二）具备履行职责所必需的财务、 ...

首创证券股份有限公司 董事会议事规则 （草案） （H 股发行上市后适用） 二零二五年八月 （于 2025 年 8 月 28 日经公司 2025 年第一次临时股东会审议通过） 目 录 首创证券股份有限公司董事会议事规则 首创证券股份有限公司 董事会议事规则 第一章 总则 第一条 为明确首创证券股份有限公司（以下简称公 司）董事会的职责权限，规范公司董事会的议事方式和决 策程序，促使公司董事和董事会有效地履行其职责，提高 公司董事会规范运作和科学决策水平，根据《中华人民共 和国公司法》（以下简称《公司法》）、《中华人民共和国证 券法》《上市公司章程指引》《上市公司治理准则》《证券公 司治理准则》《上市公司独立董事管理办法》《上海证券交 易所股票上市规则》《香港联合交易所有限公司证券上市规 则》（以下简称《香港上市规则》）等法律、法规、规范性 文件以及《首创证券股份有限公司章程》（以下简称公司章 程）的规定，制定本规则。 第二条 公司依法设立董事会，负责执行股东会的决 议。董事会是公司的经营决策机构，依据《公司法》等相 关法律、法规和公司章程的规定，经营和管理公司的法人 财产。 除职工代表董事外，其他董事由股东会选 ...

Core Points - The Supervisory Board of Beijing Shoulv Hotel (Group) Co., Ltd. held its eighth meeting of the ninth session on August 27, 2025, and unanimously approved three proposals [1][2] - The Supervisory Board expressed no objections to the company's 2025 semi-annual report, confirming that it complies with legal and regulatory requirements and accurately reflects the company's operational and financial status [1][2] - The proposal to cancel the Supervisory Board and abolish the "Supervisory Board Meeting Rules" was approved, with the responsibilities being transferred to the Audit Committee of the Board of Directors, effective from July 1, 2024 [2][3] Summary by Sections Meeting Details - The meeting was conducted via communication means with three supervisors present, and all proposals were passed unanimously [1] Semi-Annual Report - The Supervisory Board reviewed the 2025 semi-annual report and confirmed that the preparation and review processes adhered to all relevant laws, regulations, and internal management systems [1][2] - The report's content and format meet the requirements set by the China Securities Regulatory Commission and the stock exchange, ensuring that the information accurately reflects the company's management and financial conditions [2] Fund Management - The Supervisory Board reviewed the special report on the storage and actual use of raised funds for the first half of 2025, finding no objections regarding the management of idle raised funds [2] Governance Changes - The proposal to abolish the Supervisory Board will not adversely affect the company's governance or operations, and the Supervisory Board expressed gratitude for the contributions made by its members during their tenure [2][3]

Group 1 - The company will hold its second extraordinary general meeting of shareholders on September 15, 2025, using both on-site and online voting methods [1][2] - Shareholders can participate in the meeting either in person or through the Shanghai Stock Exchange's online voting system during specified time slots [1][2] - The meeting will be presided over by the company's chairman, Niu Jijun, and will include the announcement of the meeting agenda, attendance, and voting results [2] Group 2 - The meeting will review several proposals, including the election of a new non-independent director, revisions to the independent director system, and amendments to the cumulative voting system [5][6][8] - The company proposes to provide a maximum credit guarantee of up to 100 million yuan for its wholly-owned subsidiary, Gansu Mogao Hongyuan Agricultural Technology Co., Ltd., to support its operational needs [9][10]

广东安达智能装备股份有限公司 董事、高级管理人员离职管理制度 第一章 总则 第一条 为规范广东安达智能装备股份有限公司（以下简称"公司"）董事、 高级管理人员离职程序，确保公司治理结构的稳定性和连续性，维护公司及股东 的合法权益，公司根据《中华人民共和国公司法》 市公司治理准则》《上海证券交易所科创板股票上市规则》及其他有关法律法规 和《广东安达智能装备股份有限公司章程》（以下简称"《公司章程》"）的规定， 并结合公司的实际情况制定本制度。 第二条 本制度适用于公司董事（含独立董事）、高级管理人员因任期届满、 辞职、被解除职务或其他原因离职的情形。 《中华人民共和国证券法》 《上 第三条 公司董事、高级管理人员离职管理应遵循以下原则： （一）合法合规原则：严格遵守国家法律法规、监管规定及《公司章程》的 要求； （二）公开透明原则：及时、准确、完整地披露董事、高级管理人员离职相 关信息； （三）平稳过渡原则：确保董事、高级管理人员离职不影响公司正常经营和 治理结构的稳定性； （四）保护股东权益原则：维护公司及全体股东的合法权益。 第二章 离职管理机构与流程 第四条 公司董事可以在任期届满以前辞任。公司董事辞任应 ...

General Provisions - The company is established to protect the legal rights of shareholders, employees, and creditors, and to regulate its organization and behavior according to relevant laws and regulations [2][3] - The company was registered in Dongguan and approved for public offering of shares on February 25, 2022, with 20,202,020 shares issued [3][4] - The registered capital of the company is RMB 81,914,036 [3] Business Objectives and Scope - The company's business objective is to adapt to market economy requirements and leverage the advantages of its founders to achieve continuous development and good economic returns for shareholders [4][5] - The business scope includes general equipment manufacturing, software development, technical services, import and export of goods, and manufacturing and sales of industrial robots [4][5] Shares - The company's shares are issued in the form of stocks, with all shares being ordinary shares with a par value of RMB 1.00 each [5][6] - The total number of shares issued by the company is 81,914,036 [6] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, request meetings, supervise company operations, and access company documents [10][11] - Shareholders must comply with laws and regulations, pay for their subscribed shares, and cannot withdraw their capital except as legally permitted [14][41] Shareholder Meetings - The company holds annual and temporary shareholder meetings, with the annual meeting required to be held within six months after the end of the previous fiscal year [48] - Shareholder proposals must be submitted in writing and can be made by shareholders holding 1% or more of the shares [60][62] Voting and Resolutions - Ordinary resolutions require a simple majority of votes, while special resolutions require two-thirds of the votes [81][83] - Certain matters, such as capital changes and amendments to the articles of association, require special resolutions [83]

广东安达智能装备股份有限公司 审计委员会工作细则 第一章 总则 第一条 为充分发挥审计委员会对公司财务信息、内部控制、内外部审计等 工作的监督作用，健全上市公司内部监督机制，持续完善公司内控体系建设,确 保董事会对经理层的有效监督管理,不断完善公司治理结构,根据《中华人民共和 国公司法》（以下简称"《公司法》"）、《上市公司治理准则》《上海证券交易所 科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号 ——规范运作》 《广东安达智能装备股份有限公司章程》 （以下简称"《公司章程》"） 及其他有关规定，公司设立董事会审计委员会，并制定本工作细则。 第二条 董事会审计委员会是董事会设立的专门工作机构，对董事会负责， 主要负责审核公司财务信息及其披露、监督及评估内外部审计工作和内部控制， 并行使《公司法》规定的监事会的职权。 第二章 人员组成 第三条 审计委员会成员由三名董事组成，均为不在公司担任高级管理人员 的董事，应当具备履行审计委员会工作职责的专业知识和经验，其中独立董事应 当过半数，至少有一名独立董事是会计专业人士。 第四条 审计委员会委员由董事长、二分之一以上独立董事或全体董事三分 ...